OMGA - Omega Therapeutics GAAP EPS of -$0.54 beats by $0.07 revenue of $0.6M beats by $0.5M
- Omega Therapeutics press release ( NASDAQ: OMGA ): Q3 GAAP EPS of -$0.54 beats by $0.07 .
- Revenue of $0.6M beats by $0.5M .
- As of September 30, 2022, the Company had cash, cash equivalents and marketable securities totaling $148.3M.
For further details see:
Omega Therapeutics GAAP EPS of -$0.54 beats by $0.07, revenue of $0.6M beats by $0.5M